Cabergoline

71 interactions 1 explained in plain English 69 cited references

Also sold as: Dostinex®

About Cabergoline

Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men). Cabergoline is in a class of medications called dopamine rec… Read the full Cabergoline drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 12, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Sulpiride Metoclopramide Nasal Spray Aripiprazole Lauroxil Acetophenazine Alizapride Amisulpride

1 Contraindicated 69 Major

All (71) Contraindicated (1) Major (69)

Contraindicated

Cabergoline Sulpiride Decreased efficacy of either drug Details

Major

Cabergoline Amisulpride Injection Barhemsys Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Aripiprazole Injection Abilify Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Asenapine Transdermal Patch Secuado Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Acetophenazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Alizapride Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Amisulpride Barhemsys Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Aripiprazole Abilify Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Aripiprazole Lauroxil Aristada Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Asenapine Saphris Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Benperidol Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Brexpiprazole Rexulti Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Bromopride Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Bromperidol Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Cariprazine Vraylar Explained Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Chlorpromazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Chlorprothixene Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Clozapine Clozaril Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Dixyrazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Domperidone Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Droperidol Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Ethopropazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Fexofenadine Allegra Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Flupenthixol Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Fluphenazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Fluspirilene Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Haloperidol Loss of antiparkinson efficacy Details Cabergoline Iloperidone Fanapt Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Itraconazole Sporanox Increased cabergoline exposure and an increased risk of cabergoline-related adverse effects Details Cabergoline Loxapine Adasuve Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Lumateperone Caplyta Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Lurasidone Latuda Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Mesoridazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Methdilazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Methotrimeprazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Metoclopramide Diminished effectiveness of metoclopramide and the dopaminergic agent Details Cabergoline Metopimazine Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Molindone Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details Cabergoline Olanzapine Reduced efficacy of dopamine agonist Details Cabergoline Paliperidone Erzofri Reduced efficacy of cabergoline and reduced efficacy of dopamine-2 receptors Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.